| BMC Cancer | |
| Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events | |
| 关键词: Androgen receptor; Prognostic biomarker; Breast cancer; Gene regulation; Promoter methylation; Regulatory mutation; MiRNA; | |
| DOI : 10.1186/1471-2407-12-132 | |
| 来源: DOAJ | |
【 摘 要 】
Abstract
Background
Breast cancer outcome, including response to therapy, risk of metastasis and survival, is difficult to predict using currently available methods, highlighting the urgent need for more informative biomarkers. Androgen receptor (AR) has been implicated in breast carcinogenesis however its potential to be an informative biomarker has yet to be fully explored. In this study, AR protein levels were determined in a cohort of 73 Grade III invasive breast ductal adenocarcinomas.
Methods
The levels of Androgen receptor protein in a cohort of breast tumour samples was determined by immunohistochemistry and the results were compared with clinical characteristics, including survival. The role of defects in the regulation of Androgen receptor gene expression were examined by mutation and methylation screening of the 5' end of the gene, reporter assays of the 5' and 3' end of the AR gene, and searching for miRNAs that may regulate AR gene expression.
Results
AR was expressed in 56% of tumours and expression was significantly inversely associated with 10-year survival (P = 0.004). An investigation into the mechanisms responsible for the loss of AR expression revealed that hypermethylation of the
Conclusion
This study highlights the potential for AR expression to be an informative biomarker for breast cancer survival and sets the scene for a more comprehensive investigation of the molecular basis of this phenomenon.
【 授权许可】
Unknown